Featured Research

from universities, journals, and other organizations

Home health care visits after heart surgery significantly reduce risk of readmission, death

Date:
May 1, 2014
Source:
Society of Thoracic Surgeons
Summary:
Home visits by a cardiac surgery nurse practitioner (NP) following coronary artery bypass grafting (CABG) surgery can dramatically reduce a patient’s risk of hospital readmission and death 30 days after surgery, research shows. "The nurse practitioners are the key to this program's success because they provide patients they know from the hospital setting with robust continuity of care they need immediately after hospital discharge, while helping community resources better prepare for the patient handoff," said the lead investigator.

Home visits by a cardiac surgery nurse practitioner (NP) following coronary artery bypass grafting (CABG) surgery can dramatically reduce a patient's risk of hospital readmission and death 30 days after surgery, according to a study in the May 2014 issue of The Annals of Thoracic Surgery.

Michael H. Hall, MD, MBA, from North Shore University Hospital in Manhasset, NY, and colleagues implemented a pilot transitional care program, called Follow Your Heart , to evaluate the impact of home visits by hospital cardiac surgery NPs following CABG surgery.

"The goal of the Follow Your Heart program is to provide continuity of care for patients that the cardiac surgery nurse practitioners know from the hospital setting and provide robust medication management, coordinate community services, and be a communications hub for hospital and community providers," said Dr. Hall.

The study included 401 patients who underwent isolated CABG surgery at a single New York institution from May 1, 2010, to August 31, 2011. Of these patients, 169 were entered in the Follow Your Heart program, and 232 received usual care.

The researchers found that patients receiving usual care were three times more likely to be readmitted or die (one death in usual care group treated as readmission within 30 days for statistical reasons) following surgery than patients receiving NP home visits (11.54% vs. 3.85%, respectively). Previous research has shown that one in five Medicare patients (20%) is readmitted to a hospital within 30 days of discharge following CABG surgery, and most of those hospital readmissions are preventable, according to Dr. Hall.

As part of the Follow Your Heart program, patients received two home visits from an NP in the first week to 10 days after discharge, a routine surgeon office visit around 10 to 14 days after discharge, multiple phone calls from the NP, and the assurance that hospital personnel were available around the clock for questions, including an on-call surgeon. Encrypted smart phones were used to send pictures of incisions to surgeons and to email reports to hospital and community providers.

When comparing the costs for the program to the costs of the readmissions averted, the researchers found a substantial savings.

"The nurse practitioners are the key to this program's success because they provide patients they know from the hospital setting with robust continuity of care they need immediately after hospital discharge, while helping community resources better prepare for the patient handoff," said Dr. Hall. "We hope to continue our studies with patients with other medical diagnoses, such as heart failure, and determine the most efficient way for excellent, cost-efficient, and sustainable long-term care for these challenging patients."


Story Source:

The above story is based on materials provided by Society of Thoracic Surgeons. Note: Materials may be edited for content and length.


Journal Reference:

  1. Michael H. Hall, Rick A. Esposito, Renee Pekmezaris, Martin Lesser, Donna Moravick, Lynda Jahn, Robert Blenderman, Meredith Akerman, Christian N. Nouryan, Alan R. Hartman. Cardiac Surgery Nurse Practitioner Home VisitsPrevent Coronary Artery Bypass GraftReadmissions. The Annals of Thoracic Surgery, 2014; 97 (5): 1488 DOI: 10.1016/j.athoracsur.2013.12.049

Cite This Page:

Society of Thoracic Surgeons. "Home health care visits after heart surgery significantly reduce risk of readmission, death." ScienceDaily. ScienceDaily, 1 May 2014. <www.sciencedaily.com/releases/2014/05/140501075049.htm>.
Society of Thoracic Surgeons. (2014, May 1). Home health care visits after heart surgery significantly reduce risk of readmission, death. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140501075049.htm
Society of Thoracic Surgeons. "Home health care visits after heart surgery significantly reduce risk of readmission, death." ScienceDaily. www.sciencedaily.com/releases/2014/05/140501075049.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins